Bipolar Disorder I or II
Conditions
Keywords
Compassion-Focused Therapy, Older Adults, Rumination, Bipolar Disorder, Guilt, Shame
Brief summary
The aim of this study is to determine whether it is feasible to deliver a 9-session compassionate-focused therapy for older people with bipolar disorder. Participants will be asked to complete baseline measures and at post-intervention follow-up (12 weeks and 24 weeks) to understand any potential clinical benefits of the therapy.
Detailed description
The present study will evaluate the feasibility of a compassionate-focused intervention targeting rumination that is specifically tailored for older people with bipolar disorder. In addition to evaluating its feasibility, the study will also investigate whether there are any clinical benefits associated with the intervention, namely, any potential reductions in negative rumination and feelings of guilt and shame. To date, there has been no research evaluating the feasibility of this type of intervention.
Interventions
OTHERCompassionate-focused therapy
A 9-session therapy intervention targeting negative thinking, feelings of guilt and shame, and cultivating compassion for self and others.
Sponsors
Greater Manchester Mental Health NHS Foundation Trust
University of Manchester
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
60 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
* Adults aged 60 years and above. * Have a nominated healthcare professional (i.e. GP/Care Coordinator) * Meet the criteria for a diagnosis of bipolar disorder I or II according to the MINI. * Score of \>57 on Ruminative Response Scale (RRS) * Be able to provide written informed consent. * Be able to speak sufficient English to engage in the assessments and intervention.
Exclusion criteria
* Currently in an episode of mania or hypomania according to the MINI. * Experiencing 'severe depression' according to the Hamilton Depression Rating Scale, which equates to a score of over 24. * MoCA score of \<22 to exclude for moderate and severe cognitive impairment. * Currently receiving psychological therapy.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of therapy sessions attended | The timeframe for number of therapy sessions attended will span the length of intervention; from the first assessment session to final therapy session. The estimated period of time over which the event is assessed is up to 9 weeks. | The primary outcome of the study is the feasibility of the compassionate-focused intervention, which will be measured using the above metric. |
| Number of participants who drop-out and at which stage of the intervention | The time frame covers first therapy session to final therapy session. The estimated period of time over which the event is assessed is up to 9 weeks. | The primary outcome of the study is the feasibility of the compassionate-focused intervention, which will be measured using the above metric. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Other as Shamer Scale | Changes in outcome measure scores will be recorded from first baseline, to 12 weeks and 24 weeks follow-up | Any preliminary potential clinical benefits will be determined using the following outcome measures. |
| Guilt and Shame Questionnaire | Changes in outcome measure scores will be recorded from first baseline, to 12 weeks and 24 weeks follow-up | Any preliminary potential clinical benefits will be determined using the following outcome measures. |
| The Compassionate Engagement and Action Scale | Changes in outcome measure scores will be recorded from first baseline, to 12 weeks and 24 weeks follow-up | Any preliminary potential clinical benefits will be determined using the following outcome measures. |
| Generalised Anxiety Disorder Questionnaire (GAD-7) | Changes in outcome measure scores will be recorded from first baseline, to 12 weeks and 24 weeks follow-up | Any preliminary potential clinical benefits will be determined using the following outcome measures. |
| Center for Epidemiologic Studies Depression Scale (CES-D) | Changes in outcome measure scores will be recorded from first baseline, to 12 weeks and 24 weeks follow-up | Any preliminary potential clinical benefits will be determined using the following outcome measures. |
| The Altman Self-Rating Mania Scale | Changes in outcome measure scores will be recorded from first baseline, to 12 weeks and 24 weeks follow-up | Any preliminary potential clinical benefits will be determined using the following outcome measures. |
| The Bipolar Recovery Questionnaire | Changes in outcome measure scores will be recorded from first baseline, to 12 weeks and 24 weeks follow-up | Any preliminary potential clinical benefits will be determined using the following outcome measures. |
| The Quality of Life in Bipolar Disorder Questionnaire | Changes in outcome measure scores will be recorded from first baseline, to 12 weeks and 24 weeks follow-up | Any preliminary potential clinical benefits will be determined using the following outcome measures. |
Other
| Measure | Time frame | Description |
|---|---|---|
| The Montreal Cognitive Assessment (MOCA) | Eligibility portion of the baseline assessments, prior to the intervention. | Assessment of cognitive impairment. |
| The MINI International Neuropsychiatric Interview | Eligibility portion of the baseline assessments, prior to the intervention. | Diagnostic interview for Bipolar I or II. |
| Ruminative Response Scale | Eligibility portion of the baseline assessments, prior to the intervention. | Assess levels of rumination. |
| The Hamilton Depression Rating Scale | Eligibility portion of the baseline assessments, prior to the intervention. | Assess depression severity. |
Countries
United Kingdom
Contacts
Primary ContactImogen J Young, DClinPsy / MSc / BSc
Outcome results
None listed